Investor Relations

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Featured Event

Feb 3, 2015 at 4:30 PM ET
Pacific Biosciences of California, Inc. Fourth Quarter 2014 Earnings Conference Call

Recent News

March 2, 2015
Pacific Biosciences Enables Reference-Quality De Novo Human Genome Assemblies

MENLO PARK, Calif., March 2, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II Sequencing System, today announced that its Single Molec...

February 3, 2015
Pacific Biosciences Reports Fourth Quarter 2014 Financial Results

MENLO PARK, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today reported an 85% increase in revenue to $16.9 million for the fourth quarter ended Decem...

Stock Quote

Last Trade
4:00 PM ET
Mar 5, 2015
Change (%)
52 Week High
52 Week Low
Day High
Day Low


Pacific Biosciences

1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450

Supernav grey background

Supernav grey background

Super Navigation block